Anticipated expansion of a new approach to treating hypertension without medication by catheter-based renal denervation
- PMID: 30370134
- PMCID: PMC6186649
- DOI: 10.21037/jtd.2018.08.105
Anticipated expansion of a new approach to treating hypertension without medication by catheter-based renal denervation
Conflict of interest statement
Conflicts of Interest: The authors have received honoraria from Otsuka Holdings and grant support for a clinical trial of treating resistant hypertension with an ultrasonic renal denervation system.
Comment on
-
Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial.Lancet. 2018 Jun 9;391(10137):2335-2345. doi: 10.1016/S0140-6736(18)31082-1. Epub 2018 May 23. Lancet. 2018. PMID: 29803590 Clinical Trial.
References
Publication types
LinkOut - more resources
Full Text Sources